Back toDiversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.
Advertisement
The Importance of Diversity in Clinical Trials for Hepatitis C
Featured Content
video
My Story: My Hepatitis C Journey as a Black American
Pat, a hepatitis c survivor, shares her thoughts on disparity within the healthcare system.
article
Steps to Diagnosing and Getting Treatment for Hep C
What to expect during and after hep C screening and how to decide on a treatment plan.
video
6 Things Hep C Patients Need When Calling an Insurance Company
Having this important information at your fingertips will streamline the process and save you some time.
article
Why Hepatitis C is Called a "Quiet Killer"
Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.
article
Who Is at Risk for Hepatitis C?
Learn who has higher odds of contracting this viral infection.